Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBR-2q3229wPhase 3Recruiting
Phase 3, randomised, double-blind trial of hyaluronic acid, lidocaine and betamethasone dipropionate + betamethasone sodium phosphate in chondromalacia patella and patellofemoral pain syndrome (PFPS) (2 arms), sponsored by Federal University of São Paulo. Started Apr 2024; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on RBR-2q3229w.